Literature DB >> 34051704

A common genetic variant in fatty acid amide hydrolase is linked to alterations in fear extinction neural circuitry in a racially diverse, nonclinical sample of adults.

Nicole L Zabik1,2,3, Allesandra S Iadipaolo1, Hilary A Marusak3,4, Craig Peters1, Kyle Burghardt1,5, Christine A Rabinak1,2,3,4,5.   

Abstract

Poor fear extinction learning and recall are linked to the development of fear-based disorders, like posttraumatic stress disorder, and are associated with aberrant activation of fear-related neural circuitry. This includes greater amygdala activation during extinction learning and lesser hippocampal and ventromedial prefrontal cortex (vmPFC) activation during recall. Emerging data indicate that genetic variation in fatty acid amide hydrolase (FAAH C385A; rs324420) is associated with increased peripheral endocannabinoid (eCB) levels and lesser threat-related amygdala reactivity. Preclinical studies link increased eCB signaling to better extinction learning and recall, thus FAAH C385A may protect against the development of trauma-related psychopathology by facilitating extinction learning. However, how this FAAH variant affects fear extinction neural circuitry remains unknown. In the present study, we used a novel, immersive-reality fear extinction paradigm paired with functional neuroimaging to assess FAAH C385A effects on fear-related neural circuitry and conditioned fear responding (US expectancy ratings, subjective units of distress, and skin conductance responding) in healthy adults from an urban area (Detroit, MI; N = 59; C/C = 35, A-carrier = 24). We found lesser amygdala activation in A-allele carriers, compared to C/C homozygotes, during early extinction recall. Likewise, we found lesser dorsal anterior cingulate cortex and greater hippocampus activation in early extinction learning in A-carriers compared to C/C homozygotes. We found no effects of FAAH C385A on vmPFC activation or behavioral fear indices. These data support and extend previous findings that FAAH genetic variation, associated with increased eCB signaling and subsequent enhanced fear extinction, may predict individual differences in successful fear learning.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  amygdala; aversive; endocannabinoids; genetic polymorphism; magnetic resonance imaging; prefrontal cortex

Mesh:

Substances:

Year:  2021        PMID: 34051704      PMCID: PMC8628026          DOI: 10.1002/jnr.24860

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  83 in total

1.  Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.

Authors:  O Gunduz-Cinar; K P MacPherson; R Cinar; J Gamble-George; K Sugden; B Williams; G Godlewski; T S Ramikie; A X Gorka; S O Alapafuja; S P Nikas; A Makriyannis; R Poulton; S Patel; A R Hariri; A Caspi; T E Moffitt; G Kunos; A Holmes
Journal:  Mol Psychiatry       Date:  2012-06-12       Impact factor: 15.992

2.  Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.

Authors:  David J Rademacher; Sarah E Meier; Leyu Shi; W-S Vanessa Ho; Abbas Jarrahian; Cecilia J Hillard
Journal:  Neuropharmacology       Date:  2007-06-29       Impact factor: 5.250

Review 3.  Neuromodulatory functions of the endocannabinoid system.

Authors:  G Marsicano; B Lutz
Journal:  J Endocrinol Invest       Date:  2006       Impact factor: 4.256

4.  Event-related fMRI: characterizing differential responses.

Authors:  K J Friston; P Fletcher; O Josephs; A Holmes; M D Rugg; R Turner
Journal:  Neuroimage       Date:  1998-01       Impact factor: 6.556

5.  Impact of FAAH genetic variation on fronto-amygdala function during emotional processing.

Authors:  Anne Gärtner; Denise Dörfel; Kersten Diers; Stephanie H Witt; Alexander Strobel; Burkhard Brocke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-10-05       Impact factor: 5.270

6.  Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.

Authors:  I Katona; E A Rancz; L Acsady; C Ledent; K Mackie; N Hajos; T F Freund
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

7.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

8.  Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.

Authors:  Sachin Patel; Craig T Roelke; David J Rademacher; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

9.  Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial.

Authors:  Leah M Mayo; Anna Asratian; Johan Lindé; Maria Morena; Roosa Haataja; Valter Hammar; Gaëlle Augier; Matthew N Hill; Markus Heilig
Journal:  Biol Psychiatry       Date:  2019-08-13       Impact factor: 13.382

Review 10.  The prevalence of PTSD and major depression in the global population of adult war survivors: a meta-analytically informed estimate in absolute numbers.

Authors:  Thole Hilko Hoppen; Nexhmedin Morina
Journal:  Eur J Psychotraumatol       Date:  2019-02-22
View more
  1 in total

1.  In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure - a multimodal imaging study with PET, 1H-MRS, and MRI.

Authors:  Jeremy J Watts; Elisa Guma; Sofia Chavez; Rachel F Tyndale; Ruth A Ross; Sylvain Houle; Alan A Wilson; Mallar Chakravarty; Pablo M Rusjan; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2022-07-29       Impact factor: 8.294

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.